Last edition
News about "SPVX02"
World-First Fridge-Free Tetanus-Diphtheria Vaccine Trial Shows Promising Results
Stablepharma’s SPVX02 remains potent for up to two years at temperatures of up to 30°C, potentially reducing cold-chain dependence, vaccine wastage and barriers to immunisation in remote regions.
SPVX02 | 10/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members